يحاول ذهب - حر
HCL Q3 profit up 5.5% to ₹4,591 cr; revenue rises 5%
January 14, 2025
|The New Indian Express Bengaluru
IT services major HCLTech on Monday met Street expectations and posted a 5.5% increase in its consolidated net profit at ₹4,591 crore compared to ₹4,350 crore in the year-ago period, mainly driven by its broad-based performance across business verticals.
The company's revenue from operations stood at ₹29,890 crore for the quarter ending December 2024, a growth of 5.1% year-on-year (YoY) compared to ₹28,446 crore reported in the same quarter the previous year. The company's third-quarter EBIT (earnings before interest and taxes) margins came in at 19.5%.
The company has declared a fourth interim dividend of ₹18 per equity share for the current financial year (FY25). This includes a special dividend of ₹6 per share to celebrate 25 years of the company's public listing.
For FY25, the company's revenue growth is expected to be between 4.5% and 5.0% YoY and EBIT margin to be between 18% and 19%.
هذه القصة من طبعة January 14, 2025 من The New Indian Express Bengaluru.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من The New Indian Express Bengaluru
The New Indian Express Bengaluru
India, Germany intent on def ties
Two countries announce road map for joint military production, naval exercises & training
2 mins
January 13, 2026
The New Indian Express Bengaluru
'HINDI CINEMA HAS LEARNT THE WRONG LESSONS FROM HOLLYWOOD'
Vivaan Shah, who delivered an impressive performance in a brief role in Ikkis, talks about how Sriram Raghavan is an inclusive filmmaker, what he despises about current mainstream cinema, and more
3 mins
January 13, 2026
The New Indian Express Bengaluru
Trade talks back, India on Pax Silica: Gor
SIGNALLING an early effort to stabilise India-US ties that have come under strain amid tariff disputes and market jitters, Washington's new ambassador to New Delhi, Sergio Gor, on Monday said the two sides will take up the outstanding trade issues during a call on Tuesday.
1 min
January 13, 2026
The New Indian Express Bengaluru
PSLV’s third-stage fails for second time in a row
Even as AI-driven deals lifted revenues for India’s top IT firms in the December quarter, new labour codes weighed heavily on profits
1 min
January 13, 2026
The New Indian Express Bengaluru
'Quality is not linked to price'
DR Cyriac Abby Philips, clinician-scientist and president of the Mission for Ethics and Science in Health (MESH) explains the motivation behind the study, its surprising findings, and what this mean for patients and doctors alike.
1 min
January 13, 2026
The New Indian Express Bengaluru
'HINDI CINEMA HAS LEARNT THE WRONG LESSONS FROM HOLLYWOOD'
Vivaan Shah, who delivered an impressive performance in a brief role in Ikkis, talks about how Sriram Raghavan is an inclusive filmmaker, what he despises about current mainstream cinema, and more
3 mins
January 13, 2026
The New Indian Express Bengaluru
'Quality is not linked to price'
DR Cyriac Abby Philips, clinician-scientist and president of the Mission for Ethics and Science in Health (MESH) explains the motivation behind the study, its surprising findings, and what this mean for patients and doctors alike.
1 min
January 13, 2026
The New Indian Express Bengaluru
2 die in Indore due to water contamination, 9 in hospital
TWO more deaths have reportedly happened in the country’s cleanest city, Indore, due to contaminated water triggering a diarrhoea outbreak, taking the toll to 23 to date.
1 mins
January 13, 2026
The New Indian Express Bengaluru
SC to examine validity of lifelong immunity to CEC and poll commissioners
THE Supreme Court on Monday decided to examine the validity of the Parliament-enacted law giving lifelong immunity from legal proceedings to Chief Election Commissioner (CEC) and Election Commissioners (ECs).
1 min
January 13, 2026
The New Indian Express Bengaluru
INDIA FACES 2nd HIGHEST ECONOMIC BURDEN DUE TO DIABETES
NDIA faces the second highest economic burden of $11.4 trillion due to diabetes —the US bears the highest costs at $16.5 trillion, and China the third at $11 trillion, a new study has estimated.
2 mins
January 13, 2026
Listen
Translate
Change font size
